The general rule has been that only men with low-risk prostate cancer are suitable as possible candidates for active surveillance. Low risk is defined as a PSA < 10 ng/ml; a Gleason score of ≤ 6; and a clinical stage of ≤ T2aN0M0. Having said that, it should also be realized that in his series […]![]()
